跳至主要内容
临床试验/NCT02139020
NCT02139020招募中不适用

Prospective Collection of Plasma Samples From Patients Treated With Molecular Targeted Therapies for Squamous Cell Carcinoma of the Head and Neck

Cliniques universitaires Saint-Luc- Université Catholique de Louvain5 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2013年2月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400
试验地点
5
主要终点
Prospective storage of plasma samples of patients treated with cetuximab or other targeted agents

研究概览

简要总结

The investigators will collect plasma samples at baseline, during treatment, and at progression.

详细描述

In this study, the investigators will collect plasma samples at baseline, during treatment, and at progression. This plasma bank will be used to study the potential value of some biomarkers to predict treatment activity or resistance to cetuximab or other targeted agents

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients treated with radiation therapy and cetuximab according to Bonner et al
  • patients treated with cetuximab in combination with chemotherapy according to Vermorken et al.
  • patients treated with a molecular targeted agent as a part of a clinical study

排除标准

  • patients with another type of head and neck cancer
  • patients non treated with targeted therapies

结局指标

主要结局

Prospective storage of plasma samples of patients treated with cetuximab or other targeted agents

时间窗: one year after the collection

All the analyses will be done when we have enough of collected samples

次要结局

未报告次要终点

研究者

发起方
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

Collection of Plasma Samples for Squamous Cell... | 临床试验